Literature DB >> 9596481

Tumor oxygenation correlates with molecular growth determinants in breast cancer.

P Hohenberger1, C Felgner, W Haensch, P M Schlag.   

Abstract

UNLABELLED: Hypoxic tumor cells may represent a fraction of cells that are not susceptible to radiation or chemotherapy. Intratumoral oxygen partial pressure (pO2) is the result of oxygen delivery and consumption. Cell proliferation is one factor to effect oxygen consumption and we therefore studied the correlation between tumor pO2 and histological parameters. PATIENTS AND METHODS: In 36 women and one man (age range 29-80 years) with suspected breast cancer. Before tumor resection, intralesional pO2 was determined with a polarographic needle electrode. Under ultrasound control, 200 tumor measurements were obtained; Hb levels, Hk, arterial blood gas parameters, and tissue temperature were determined. The median of pO2 values and the percentage of hypoxic areas (pO2 < 10 mmHg) were calculated and correlated with the histological type, grading, ER, PR, and the expression of Ki-67, p53, EGFR, pS2, and c-erb-B2.
RESULTS: The overall median pO2 was 44 mmHg, and 1024 measurements (13.8%) represented hypoxic areas. Ductal and lobular invasive cancers showed median pO2 of 41 mmHg. The mean pO2 of G1 tumors was 59 mmHg and the hypoxic fraction 8%, in contrast to G2 tumors with 43 mmHg and 17%, and G3 tumors with 36 mmHg and 20.4% (p < 0.01). We observed a correlation with tumor size and an increased rate of hypoxic areas in T3-4 lesions (p < 0.02). Also tumors with negative nodes or positive ER had significantly higher pO2 values, as did tumors with an overexpression of c-erb-B2, p53, and cathepsin D.
CONCLUSION: Oxygenation of human breast cancers can safely be measured in patients prior to surgical therapy. pO2 values correlate both with prognostic markers examined histologically and with molecular growth factors. As the efficacy of preoperative or adjuvant treatment in individuals may depend on oxygen partial pressure, efforts to manipulate tumor pO2 for therapeutic purpose could be promising.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596481     DOI: 10.1023/a:1005921513083

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.

Authors:  Shigeto Ueda; Darren Roblyer; Albert Cerussi; Amanda Durkin; Anais Leproux; Ylenia Santoro; Shanshan Xu; Thomas D O'Sullivan; David Hsiang; Rita Mehta; John Butler; Bruce J Tromberg
Journal:  Cancer Res       Date:  2012-07-09       Impact factor: 12.701

2.  Modeling the effect of tumor size in early breast cancer.

Authors:  Claire Verschraegen; Vincent Vinh-Hung; Gábor Cserni; Richard Gordon; Melanie E Royce; Georges Vlastos; Patricia Tai; Guy Storme
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

Review 3.  Employing tumor hypoxia for oncolytic therapy in breast cancer.

Authors:  Yun Shin Chun; Prasad S Adusumilli; Yuman Fong
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

4.  Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results.

Authors:  Andreas Stadlbauer; Max Zimmermann; Barbara Bennani-Baiti; Thomas H Helbich; Pascal Baltzer; Paola Clauser; Panagiotis Kapetas; Zsuzsanna Bago-Horvath; Katja Pinker
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 5.  Hypoxia-inducible factor 1 and breast cancer metastasis.

Authors:  Zhao-Ji Liu; Gregg L Semenza; Hua-Feng Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

6.  Imaging tumor oxyhemoglobin and deoxyhemoglobin concentrations with ultrasound-guided diffuse optical tomography.

Authors:  Nrusingh C Biswal; Yan Xu; Quing Zhu
Journal:  Technol Cancer Res Treat       Date:  2011-10

7.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

8.  Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

Authors:  J Quincy Brown; Lee G Wilke; Joseph Geradts; Stephanie A Kennedy; Gregory M Palmer; Nirmala Ramanujam
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 9.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12

10.  In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.

Authors:  Bagna Bao; Kevin Groves; Jun Zhang; Emma Handy; Paul Kennedy; Garry Cuneo; Claudiu T Supuran; Wael Yared; Milind Rajopadhye; Jeffrey D Peterson
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.